MARÍA ISABEL
TEJADA MÍNGUEZ
Chercheuse jusqu' 2019
Hospital Miguel Servet
Zaragoza, EspañaPublications en collaboration avec des chercheurs de Hospital Miguel Servet (11)
2020
-
Effect of AGG Interruptions on FMR1 Maternal Transmissions
Frontiers in Molecular Biosciences, Vol. 7
-
Molecular characterization of Spanish patients with MECP2 duplication syndrome
Clinical Genetics, Vol. 97, Núm. 4, pp. 610-620
-
Role of mitochondrial DNA variants in the development of fragile X-associated tremor/ataxia syndrome
Mitochondrion, Vol. 52, pp. 157-162
2018
-
Clinical implication of FMR1 intermediate alleles in a Spanish population
Clinical Genetics, Vol. 94, Núm. 1, pp. 153-158
2014
-
Molecular testing for fragile X: Analysis of 5062 tests from 1105 fragile X families - Performed in 12 clinical laboratories in Spain
BioMed Research International, Vol. 2014
2013
-
Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases
PLoS ONE, Vol. 8, Núm. 7
-
MECP2 gene study in a large cohort: Testing of 240 female patients and 861 healthy controls (519 females and 342 males)
Journal of Molecular Diagnostics, Vol. 15, Núm. 5, pp. 723-729
2012
-
CDKL5 gene status in female patients with epilepsy and Rett-like features: two new mutations in the catalytic domain
BMC Medical Genetics, Vol. 13
-
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer
Breast Cancer Research and Treatment, Vol. 132, Núm. 1, pp. 307-315
2010
-
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
Breast Cancer Research and Treatment, Vol. 119, Núm. 1, pp. 221-232
2008
-
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain
Clinical Cancer Research, Vol. 14, Núm. 9, pp. 2861-2869